United Health Products (UEEC) Stock Price, News & Analysis

Company Overview

United Health Products, Inc. (OTCMKTS:UEEC) is a U.S.-based manufacturer and distributor of dietary supplements and cosmetic products designed to support overall wellness and beauty. The company’s core offerings include vitamins, minerals, herbal and nutraceutical formulations that target skin, hair and nail health. United Health Products operates FDA-inspected production facilities in the United States, ensuring cGMP compliance and rigorous quality control, while leveraging strategic partnerships with contract manufacturers in Asia to enhance cost efficiencies and meet growing global demand.

Founded in the early 1990s, United Health Products has steadily expanded its product portfolio and international footprint. In 2001, the company established a trading subsidiary in Hong Kong to streamline distribution across key Asian markets such as China, Taiwan and Southeast Asia. This move facilitated the introduction of region-specific formulations and cosmetic lines under proprietary brands, positioning UEEC to capitalize on rising consumer interest in preventative healthcare and “beauty from within” supplements.

United Health Products employs a multi-channel go-to-market strategy that combines traditional wholesale distribution, direct sales through licensed practitioners and an evolving e-commerce platform. The company’s digital sales channels have been enhanced with targeted marketing campaigns and strategic alliances, allowing UEEC to strengthen its presence in both mature and emerging markets. Continued investment in research and development underpins its product innovation, with proprietary formulations often supported by clinical and scientific studies.

The business is guided by an experienced leadership team and board of directors with backgrounds in healthcare, regulatory affairs and global marketing. Led by Chief Executive Officer John D. Logan and Chief Financial Officer Sarah J. Wells, the executive team focuses on sustainable growth, operational excellence and geographic expansion. Looking ahead, United Health Products aims to broaden its international reach, accelerate new product launches and deepen its footprint in fast-growing sectors of the nutraceutical and cosmetic industries.

Key Stats

• Today's Range: $0.09 to $0.10
• 50-Day Range: $0.09 to $0.25
• 52-Week Range: $0.05 to $0.28
• Volume: 39,821 shs
• Average Volume: 195,467 shs
• Market Capitalization: $24.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UEEC Stock Analysis - Frequently Asked Questions

How have UEEC shares performed this year?

United Health Products' stock was trading at $0.0531 at the beginning of 2025. Since then, UEEC stock has increased by 78.9% and is now trading at $0.0950.

How were United Health Products' earnings last quarter?

United Health Products, Inc. (OTCMKTS:UEEC) released its quarterly earnings data on Friday, March, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

How do I buy shares of United Health Products?

Shares of UEEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of United Health Products own?

Based on aggregate information from My MarketBeat watchlists, some other companies that United Health Products investors own include UnitedHealth Group (UNH), Bank of America (BAC), NVIDIA (NVDA), Quantum Materials (QTMM), Salesforce (CRM), Cisco Systems (CSCO) and Johnson & Johnson (JNJ).

Company Calendar

• Last Earnings: 3/28/2025
• Today: 7/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:UEEC
• CIK: 1096938
• Web: www.unitedhealthproductsinc.com
• Phone: (475) 755-1005
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -1,905.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.02
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: $40 thousand
• Price / Sales: 608.38
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -9.50

Miscellaneous

• Outstanding Shares: 256,160,000
• Free Float: 252,316,000
• Market Cap: $24.34 million
• Optionable: Not Optionable
• Beta: -1.50